Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SyB P-1501 (Fentanyl) for Postoperative Pain
NCT03005899Phase 3Terminated
- Sponsor
- SymBio Pharmaceuticals
- Start
- Nov 2016
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl in postoperative pain, sponsored by SymBio Pharmaceuticals. Started Nov 2016; status: terminated.
02
Drugs
fentanyl
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03005899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03005899.